Clinical Trial Detail

NCT ID NCT01248949
Title A Study to Evaluate the Safety and Antitumor Activity in Subjects With Advanced Solid Tumors
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors MedImmune LLC
Indications

Advanced Solid Tumor

ovarian cancer

Therapies

Bevacizumab

MEDI3617

Gemcitabine

Carboplatin

Paclitaxel

Age Groups: adult senior

No variant requirements are available.